Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tapentadol 50mg modified-release tablets
0407020AGAAACAC
|
Tapentadol | Tapentadol | Central Nervous System | 12,889 |
|
Tapentadol 100mg modified-release tablets
0407020AGAAADAD
|
Tapentadol | Tapentadol | Central Nervous System | 10,293 |
|
Tapentadol 50mg tablets
0407020AGAAAAAA
|
Tapentadol | Tapentadol | Central Nervous System | 9,707 |
|
Tapentadol 150mg modified-release tablets
0407020AGAAAEAE
|
Tapentadol | Tapentadol | Central Nervous System | 4,204 |
|
Tapentadol 200mg modified-release tablets
0407020AGAAAFAF
|
Tapentadol | Tapentadol | Central Nervous System | 4,025 |
|
Tapentadol 250mg modified-release tablets
0407020AGAAAGAG
|
Tapentadol | Tapentadol | Central Nervous System | 1,936 |
|
Tapentadol 25mg modified-release tablets
0407020AGAAAIAI
|
Tapentadol | Tapentadol | Central Nervous System | 728 |
|
Tapentadol 75mg tablets
0407020AGAAABAB
|
Tapentadol | Tapentadol | Central Nervous System | 668 |
|
Tapentadol 20mg/ml oral solution sugar free
0407020AGAAAHAH
|
Tapentadol | Tapentadol | Central Nervous System | 222 |
|
Tapentadol 50mg modified-release capsules
0407020AGAAAJAJ
|
Tapentadol | Tapentadol | Central Nervous System | 14 |
|
Tapentadol 100mg modified-release capsules
0407020AGAAAKAK
|
Tapentadol | Tapentadol | Central Nervous System | 10 |
|
Tapentadol 150mg modified-release capsules
0407020AGAAALAL
|
Tapentadol | Tapentadol | Central Nervous System | 9 |
|
Tapentadol 200mg modified-release capsules
0407020AGAAAMAM
|
Tapentadol | Tapentadol | Central Nervous System | 3 |
|
Tapentadol 250mg modified-release capsules
0407020AGAAANAN
|
Tapentadol | Tapentadol | Central Nervous System | 1 |
|
Tapentadol 100mg tablets
0407020AGAAAPAP
|
Tapentadol | Tapentadol | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.